Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference
Representatives from academia, industry, regulatory agencies, and patient groups convened in March 2019 with the primary goal of developing agreement on chronic hepatitis B virus (HBV) treatment endpoints to guide clinical trials aiming to 'cure' HBV. Agreement among the conference partici...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
2019
|
| Online Erişim: | https://doi.org/10.1002/hep.31030 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.31030 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|